Anticancer Drug Development Guide

Name: Anticancer Drug Development Guide
Brand: Humana Press Inc.
SKU: 9781468498417
Price: 154.28 EUR
Availability: InStock

Preclinical Screening, Clinical Trials, and Approval

Автор: Beverly A. Teicher, Paul A. Andrews

Език:

Корици: С меки корици

Издател: Humana Press Inc.

Наличност: Външен склад

Изпращаме след 5-8 дни

154.28 € 301.75 лв

This unique volume traces the critically important pathway by which a "molecule" becomes an "antican...

Информация за книгата

Автор

Beverly A. Teicher, Paul A. Andrews

Език

Английски език

Корици

Книга - С меки корици

Издадена

2012

страници

451

EAN

9781468498417

ISBN

146849841X

Enbook ID

05258311

Издател

Humana Press Inc.

Теглоt

883

Размери

178 x 254 x 26

Пълно описание

This unique volume traces the critically important pathway by which a "molecule" becomes an "anticancer agent. " The recognition following World War I that the administration of toxic chemicals such as nitrogen mustards in a controlled manner could shrink malignant tumor masses for relatively substantial periods of time gave great impetus to the search for molecules that would be lethal to specific cancer cells. Weare still actively engaged in that search today. The question is how to discover these "anticancer" molecules. Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval, Second Edition describes the evolution to the present of preclinical screening methods. The National Cancer Institute's high-throughput, in vitro disease-specific screen with 60 or more human tumor cell lines is used to search for molecules with novel mechanisms of action or activity against specific phenotypes. The Human Tumor Colony-Forming Assay (HTCA) uses fresh tumor biopsies as sources of cells that more nearly resemble the human disease. There is no doubt that the greatest successes of traditional chemotherapy have been in the leukemias and lymphomas. Since the earliest widely used in vivo drug screening models were the murine L 1210 and P388 leukemias, the community came to assume that these murine tumor models were appropriate to the discovery of "antileukemia" agents, but that other tumor models would be needed to discover drugs active against solid tumors.

Може също да ви хареса

Клиенти, които купиха тази книга, купиха също

Най-често търсени

Categories

Authors

Publishers

Продукти

Продукти

Най-често търсени

Categories

Authors

Publishers

Продукти

Продукти

Anticancer Drug Development Guide

Preclinical Screening, Clinical Trials, and Approval

Информация за книгата

Пълно описание

Може също да ви хареса

Клиенти, които купиха тази книга, купиха също